Effectiveness and Safety of Dual Therapy With Rilpivirine and Boosted Darunavir in Treatment-Experienced Patients With Advanced HIV Infection: A Preliminary 24 Week Analysis (RIDAR Study)

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-019-3817-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients

PLoS ONE
Multidisciplinary
2019English

Boosted Tipranavir Versus Darunavir in Treatment-Experienced Patients

Drugs in R and D
Pharmacology
2011English

Efficacy and Safety of Darunavir and Etravirine in an Antiretroviral Multi-Experienced Youth With Vertically HIV-1 Infection

European Journal of Medical Research
Medicine
2009English

Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients With HIV Type 1 Infection

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

miR-29a Associates With Viro-Immunological Markers of HIV Infection in Treatment Experienced Patients

Journal of Medical Virology
VirologyInfectious Diseases
2016English

Effectiveness, Durability, and Safety of Darunavir/Ritonavir in HIV-1-infected Patients in Routine Clinical Practice in Italy: A Postauthorization Noninterventional Study

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women With HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2018English

ASSOCIATION BEETWEEN IL-28β POLYMORPHISMS AND EFFECTIVENESS OF CONCOMITANT THERAPY OF HIV INFECTION IN PATIENTS WITH HCV/HIV CO-INFECTION DURING THE ANTIVIRAL THERAPY

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy